For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251114:nRSN5931Ha&default-theme=true
RNS Number : 5931H Avingtrans PLC 14 November 2025
14 November 2025
Avingtrans Plc
("Avingtrans", the "Company", or the "Group")
Exercise of Options & PDMR Dealings
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, announces that on 13 November 2025, the Company was
notified of the exercise of 591,614 options over ordinary shares of 5p each in
the Company ("Ordinary Shares") by Steve McQuillan, Chief Executive Officer,
and Stephen King, Chief Financial Officer, pursuant to the Company's Executive
Shared Ownership Plans (the "ExSOP Options").
Details of the exercise of ExSOP Options by Steve McQuillan and Stephen King,
together with subsequent beneficial holdings of each individual following the
transactions, are set out below.
PDMR Role FY 2019 ExSOP options exercised FY 2016 ExSOP options exercised Beneficial interest in Ordinary Shares following the transactions Resulting percentage holding of enlarged total voting rights held
Steve McQuillan Chief Executive Officer 77,061 258,877 806,925 2.44%
Stephen King Chief Financial Officer 68,254 187,422 667,614 2.02%
The 591,614 Ordinary Shares are currently held by the Company's Employee
Benefit Trust and will be transferred to Steve McQuillan and Stephen King and,
as such, no new Ordinary Shares have been issued in connection with the
transactions.
Therefore, the total number of Ordinary Shares with voting rights in the
Company remains at 33,130,422. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in the
Group under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.
Enquiries:
Avingtrans plc 01354 692 391
Roger McDowell, Chairman
Steve McQuillan, Chief Executive Officer
Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker) 020 7496 3000
Sara Hale
Alex Bond
Oliver Platts
IFC Advisory (Financial PR) 020 3934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and
associated aftermarket services to the energy, medical and industrial markets
worldwide.
Business units
Hayward Tyler - Luton, East Kilbride UK, USA, China and India
Specialises in the design, manufacture and servicing of performance-critical
motors and pumps for challenging environments.
Energy Steel, Inc - Rochester Hills, Michigan, USA
Provider of custom fabrications for the nuclear industry, specialising in: OEM
parts obsolescence; custom fabrications; engineering design solutions; product
refurbishment; on-site technical support.
Stainless Metalcraft Ltd - Chatteris, UK
Provider of safety-critical equipment for the energy, medical, science and
research communities, worldwide, specialising in precision pressure and vacuum
vessels and associated fabrications, sub-assemblies and systems.
Booth Industries - Bolton, UK
Designs, manufactures, installs and services doors and walls which can be
tailored to be: blast and explosion proof; fireproof; acoustically shielded;
high security/safety; or combinations of the above.
Ormandy Group - Bradford, UK
Design, manufacturers and servicing of off-site plant, heat exchangers and
other HVAC (heating, ventilation and air conditioning) products.
Slack & Parr - Kegworth, UK, USA & China
Design, manufacture and servicing of high-precision gear metering pumps,
hydraulics flow dividers and industrial pumps.
Composite Products Ltd - Buckingham, UK
Centre for composite technology, parts and assemblies, serving customers in
industrial markets.
Adaptix Ltd - Oxford, UK
Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary
applications amongst others. Commercialisation of this system (and others) is
on-going.
Magnetica Ltd - Brisbane, Australia
Magnetica Limited specialises in the development of next generation MRI
technologies, including dedicated extremity MRI systems and MRI system
components. Magnetica has successfully built and tested a compact, integrated
3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging.
Commercialisation of this system (and others) is on-going. Magnetica's
structure now includes two other business units:
Scientific Magnetics - Abingdon, UK
Designs and manufactures superconducting magnet systems and associated
cryogenics for a variety of markets including MRI and provides services for
Nuclear Magnetic Resonance instruments.
Tecmag Inc - Houston, USA
Designs, manufactures and installs instrumentation, including consoles, system
upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear
Magnetic Resonance (NMR) systems.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Steve McQuillan
2. Stephen King
2 Reason for the notification
a) Position/status 1. Chief Executive Officer
2. Chief Financial Officer
Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avingtrans PLC
b) LEI 213800ZZ96CKPI423E86
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 5p each
Identification code ISIN: GB0009188797
b) Nature of the transaction Exercise of options pursuant to the FY 2019 ExSOP
c) Price(s) and volume(s)
Price(s) Volume(s)
1. 520.0p 77,061
2. 520.0p 68,254
d) Aggregated information n/a
- Aggregated volume
- Price
e) Date of the transaction 13 November 2025
f) Place of the transaction Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
13 November 2025
f)
Place of the transaction
Off market
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Steve McQuillan
2. Stephen King
2 Reason for the notification
a) Position/status 1. Chief Executive Officer
2. Chief Financial Officer
Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Avingtrans PLC
b) LEI 213800ZZ96CKPI423E86
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 5p each
Identification code ISIN: GB0009188797
b) Nature of the transaction Exercise of options pursuant to the FY 2016 ExSOP
c) Price(s) and volume(s)
Price(s) Volume(s)
1. 520.0p 258,877
2. 520.0p 187,422
d) Aggregated information n/a
- Aggregated volume
- Price
e) Date of the transaction 13 November 2025
f) Place of the transaction Off market
d)
Aggregated information
n/a
- Aggregated volume
- Price
e)
Date of the transaction
13 November 2025
f)
Place of the transaction
Off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBIBPTMTJBMAA
Copyright 2019 Regulatory News Service, all rights reserved